The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1319000
WO Application Number:
SE2001002008
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP01970421.2
WO Publication Number:
WO2002024692
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:
Dates
Filing date:
19/09/2001
Grant date:
05/11/2008
EP Publication Date:
05/11/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/11/2008
EP B1 Publication Date:
05/11/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
18/09/2021
Lapsed By Expiration Date:
19/09/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
04/10/2019
Name:
Aprea Therapeutics AB
Address:
Nobels Väg 16, 171 65, SOLNA , Sweden (SE)
Historical Applicant/holder
From:
04/10/2019
To:
04/10/2019
Name:
APREA AB
Address:
Nobels Väg 16, 171 65, SOLNA, Sweden (SE)
Domicile Holder
Name:
ir. H.A. Witmans c.s.
From:
05/11/2008
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)